Day: November 1, 2017

Transparency bill could significantly impact Novo Nordisk’s business

Warning against excessive transparency, Novo Nordisk said the upcoming transparency bills could impact its growth potential in key markets. On Wednesday, drugmaker Novo Nordisk warned that the new legislation being prepared in some states in the U.S. which are aimed… Read More ›